Acute 5-HT7 receptor activation increases NMDA-evoked currents and differentially alters NMDA receptor subunit phosphorylation and trafficking in hippocampal neurons

Molecular Brain

Volumn 6, Issue 1, 2013, Pages

  Vasefi, Maryam S ^a   Yang, Kai ^b   Li, Jerry ^a   Kruk, Jeff S ^a   Heikkila, John J ^a   Jackson, Michael F ^c   Macdonald, John F ^c   Beazely, Michael A ^a  

^a UNIVERSITY OF WATERLOO   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c ROBARTS RESEARCH INSTITUTE   (Canada)

Author keywords

5 HT7; Hippocampus; Isolated neurons; NMDA; Phosphorylation; Trafficking

Indexed keywords

3 [2 [2 (4 METHYL 1 PIPERIDINYL)ETHYL] 1 PYRROLIDINESULFONYL]PHENOL; 3,N DIMETHYL N [1 METHYL 3 (4 METHYL 1 PIPERIDINYL)PROPYL]BENZENESULFONAMIDE; 5 CARBAMOYLTRYPTAMINE; GROWTH FACTOR RECEPTOR; N METHYL DEXTRO ASPARTIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 1; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 2A; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 2B; PLATELET DERIVED GROWTH FACTOR BETA RECEPTOR; SEROTONIN 7 RECEPTOR; 4-(2-DIPHENYL)-N-(1,2,3,4-TETRAHYDRONAPHTHALEN-1-YL)-1-PIPERAZINEHEXANAMIDE; 5-CARBOXAMIDOTRYPTAMINE; AMIDE; N METHYLASPARTIC ACID; PHOSPHOSERINE; PIPERAZINE DERIVATIVE; PROTEIN SUBUNIT; SEROTONIN; SEROTONIN RECEPTOR;

ANIMAL CELL; ARTICLE; BRAIN SLICE; CELL ISOLATION; CELL MIGRATION; CELL SURFACE; CONTROLLED STUDY; DRUG MECHANISM; EVOKED RESPONSE; EXCITATORY POSTSYNAPTIC POTENTIAL; HIPPOCAMPUS; NERVE CELL; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; ANALOGS AND DERIVATIVES; ANIMAL; BIOLOGICAL MODEL; CHANNEL GATING; CYTOLOGY; DRUG EFFECTS; METABOLISM; PHOSPHORYLATION; PROTEIN SUBUNIT; WISTAR RAT;

AMIDES; ANIMALS; HIPPOCAMPUS; ION CHANNEL GATING; MODELS, BIOLOGICAL; N-METHYLASPARTATE; NEURONS; PHOSPHORYLATION; PHOSPHOSERINE; PIPERAZINES; PROTEIN SUBUNITS; RATS, WISTAR; RECEPTORS, N-METHYL-D-ASPARTATE; RECEPTORS, SEROTONIN; SEROTONIN;

EID: 84877634568     PISSN: None     EISSN: 17566606     Source Type: Journal    
DOI: 10.1186/1756-6606-6-24     Document Type: Article

References (39)

1. NMDA receptor subunits: function and pharmacology. Paoletti P, Neyton J, Curr Opin Pharmacol 2007 7 39 47 10.1016/j.coph.2006.08.011 17088105 (Pubitemid 46238036)
2. NMDA di-heteromeric receptor populations and associated proteins in rat hippocampus. Al-Hallaq RA, Conrads TP, Veenstra TD, Wenthold RJ, J Neurosci 2007 27 8334 8343 10.1523/JNEUROSCI.2155-07.2007 17670980 (Pubitemid 47219608)
3. Triheteromeric NR1/NR2A/NR2B receptors constitute the major N-methyl-D-aspartate receptor population in adult hippocampal synapses. Rauner C, Kohr G, J Biol Chem 2011 286 7558 7566 10.1074/jbc.M110.182600 21190942
4. Serotonin 5-HT1A receptors regulate NMDA receptor channels through a microtubule-dependent mechanism. Yuen EY, Jiang Q, Chen P, Gu Z, Feng J, Yan Z, J Neurosci 2005 25 5488 5501 10.1523/JNEUROSCI.1187-05.2005 15944377 (Pubitemid 40800641)
5. Inhibition of NMDA-receptor mediated response in the rat medial prefrontal cortical pyramidal cells by the 5-HT3 receptor agonist SR 57227A and 5-HT: intracellular studies. Liang X, Arvanov VL, Wang RY, Synapse 1998 29 257 268 10.1002/(SICI)1098-2396(199807)29:3<257::AID-SYN8>3.0.CO;2-5 9635896 (Pubitemid 28267935)
6. Serotonin 5-HT2 receptor activation potentiates N-methyl-D-aspartate receptor-mediated ion currents by a protein kinase C-dependent mechanism. Blank T, Zwart R, Nijholt I, Spiess J, J Neurosci Res 1996 45 153 160 10.1002/(SICI)1097-4547(19960715)45:2<153::AID-JNR7>3.0.CO;2-9 8843032 (Pubitemid 26257316)
7. A pre- and postsynaptic modulatory action of 5-HT and the 5-HT2A, 2C receptor agonist DOB on NMDA-evoked responses in the rat medial prefrontal cortex. Arvanov VL, Liang X, Magro P, Roberts R, Wang RY, Eur J Neurosci 1999 11 2917 2934 10.1046/j.1460-9568.1999.00708.x 10457188 (Pubitemid 29364208)
8. Serotonin 5-HT7 receptor agents: Structure-activity relationships and potential therapeutic applications in central nervous system disorders. Leopoldo M, Lacivita E, Berardi F, Perrone R, Hedlund PB, Pharmacol Ther 2011 129 120 148 10.1016/j.pharmthera.2010.08.013 20923682
9. Neural mechanisms mediating circadian phase resetting by activation of 5-HT(7) receptors in the dorsal raphe: roles of GABAergic and glutamatergic neurotransmission. Duncan MJ, Congleton MR, Brain Res 2010 1366 110 119 20920493
10. A 5-HT7 heteroreceptor-mediated inhibition of [3H]serotonin release in raphe nuclei slices of the rat: evidence for a serotonergic-glutamatergic interaction. Harsing LG Jr, Prauda I, Barkoczy J, Matyus P, Juranyi Z, Neurochem Res 2004 29 1487 1497 15260125 (Pubitemid 38860229)
11. Serotonergic modulation of retinal input to the mouse suprachiasmatic nucleus mediated by 5-HT1B and 5-HT7 receptors. Smith BN, Sollars PJ, Dudek FE, Pickard GE, J Biol Rhythms 2001 16 25 38 10.1177/074873040101600104 11220775 (Pubitemid 32175303)
12. Serotonin modulates glutamate responses in isolated suprachiasmatic nucleus neurons. Quintero JE, McMahon DG, J Neurophysiol 1999 82 533 539 10444653 (Pubitemid 29387830)
13. Mice lacking 5-HT receptors show specific impairments in contextual learning. Roberts AJ, Krucker T, Levy CL, Slanina KA, Sutcliffe JG, Hedlund PB, Eur J Neurosci 2004 19 1913 1922 10.1111/j.1460-9568.2004.03288.x 15078565 (Pubitemid 38482579)
14. Pharmacological characterization of a serotonin receptor (5-HT7) stimulating cAMP production in human corneal epithelial cells. Crider JY, Williams GW, Drace CD, Katoli P, Senchyna M, Sharif NA, Invest Ophthalmol Vis Sci 2003 44 4837 4844 10.1167/iovs.02-1292 14578406 (Pubitemid 37315298)
15. 5-HT7 receptor is coupled to G alpha subunits of heterotrimeric G12-protein to regulate gene transcription and neuronal morphology. Kvachnina E, Liu G, Dityatev A, Renner U, Dumuis A, Richter DW, Dityateva G, Schachner M, Voyno-Yasenetskaya TA, Ponimaskin EG, J Neurosci 2005 25 7821 7830 10.1523/JNEUROSCI.1790-05.2005 16120784 (Pubitemid 41208654)
16. Activation of 5-HT7 receptors increases neuronal platelet-derived growth factor beta receptor expression. Vasefi MS, Kruk JS, Liu H, Heikkila JJ, Beazely MA, Neurosci Lett 2012 511 65 69 10.1016/j.neulet.2012.01.016 22285262
17. Platelet-derived growth factor selectively inhibits NR2B-containing N-methyl-D-aspartate receptors in CA1 hippocampal neurons. Beazely MA, Lim A, Li H, Trepanier C, Chen X, Sidhu B, Macdonald JF, J Biol Chem 2009 284 8054 8063 10.1074/jbc.M805384200 19106110
18. 5-HT7 receptor neuroprotection against NMDA-induced excitotoxicity is PDGFß receptor-dependent. Vasefi MS, Kruk JS, Heikkila JJ, Beazely MA, J Neurochem 2013 125 26 36 10.1111/jnc.12157 23336565
19. The 5-HT7 receptor: orphan found. Eglen RM, Jasper JR, Chang DJ, Martin GR, Trends Pharmacol Sci 1997 18 104 107 10.1016/S0165-6147(97)01043-2 9149537 (Pubitemid 27168251)
20. International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (Serotonin). Hoyer D, Clarke DE, Fozard JR, Hartig PR, Martin GR, Mylecharane EJ, Saxena PR, Humphrey PP, Pharmacol Rev 1994 46 157 203 7938165 (Pubitemid 24185150)
21. Functional expression of the serotonin 5-HT7 receptor in human glioblastoma cell lines. Mahe C, Bernhard M, Bobirnac I, Keser C, Loetscher E, Feuerbach D, Dev KK, Schoeffter P, Br J Pharmacol 2004 143 404 410 10.1038/sj.bjp.0705936 15339860 (Pubitemid 39424829)
22. Reanalysis of constitutively active rat and human 5-HT7(a) receptors in HEK-293F cells demonstrates lack of silent properties for reported neutral antagonists. Romero G, Pujol M, Pauwels PJ, Naunyn Schmiedebergs Arch Pharmacol 2006 374 31 39 10.1007/s00210-006-0093-y 16967291
23. Activation of adenylyl cyclase by endogenous G(s)-coupled receptors in human embryonic kidney 293 cells is attenuated by 5-HT(7) receptor expression. Andressen KW, Norum JH, Levy FO, Krobert KA, Mol Pharmacol 2006 69 207 215 16189297 (Pubitemid 43048907)
24. The cloned human 5-HT7 receptor splice variants: a comparative characterization of their pharmacology, function and distribution. Krobert KA, Bach T, Syversveen T, Kvingedal AM, Levy FO, Naunyn Schmiedebergs Arch Pharmacol 2001 363 620 632 10.1007/s002100000369 11414657 (Pubitemid 32477270)
25. The endogenous lipid oleamide activates serotonin 5-HT7 neurons in mouse thalamus and hypothalamus. Thomas EA, Cravatt BF, Sutcliffe JG, J Neurochem 1999 72 2370 2378 10349846 (Pubitemid 29242187)
26. Structure-activity relationship study on N-(1,2,3,4-tetrahydronaphthalen- 1-yl)-4-aryl-1-piperazinehexanamides, a class of 5-HT7 receptor agents. 2. Leopoldo M, Lacivita E, Contino M, Colabufo NA, Berardi F, Perrone R, J Med Chem 2007 50 4214 4221 10.1021/jm070487n 17649988 (Pubitemid 47301752)
27. Differential inverse agonist efficacies of SB-258719, SB-258741 and SB-269970 at human recombinant serotonin 5-HT7 receptors. Mahe C, Loetscher E, Feuerbach D, Muller W, Seiler MP, Schoeffter P, Eur J Pharmacol 2004 495 97 102 10.1016/j.ejphar.2004.05.033 15249157 (Pubitemid 38891865)
28. 5-Hydroxytryptamine(7) receptor activation decreases slow afterhyperpolarization amplitude in CA3 hippocampal pyramidal cells. Bacon WL, Beck SG, J Pharmacol Exp Ther 2000 294 672 679 10900247 (Pubitemid 30490844)
29. 5-HT7 receptors increase the excitability of rat hippocampal CA1 pyramidal neurons. Tokarski K, Zahorodna A, Bobula B, Hess G, Brain Res 2003 993 230 234 10.1016/j.brainres.2003.09.015 14642852 (Pubitemid 37464603)
30. Platelet-derived growth factor induces a long-term inhibition of N-methyl-D-aspartate receptor function. Valenzuela CF, Xiong Z, MacDonald JF, Weiner JL, Frazier CJ, Dunwiddie TV, Kazlauskas A, Whiting PJ, Harris RA, J Biol Chem 1996 271 16151 16159 10.1074/jbc.271.27.16151 8663218 (Pubitemid 26236232)
31. Effects of the 5-HT7 receptor antagonists SB-269970 and DR 4004 in autoshaping Pavlovian/instrumental learning task. Meneses A, Behav Brain Res 2004 155 275 282 10.1016/j.bbr.2004.04.026 15364487 (Pubitemid 39208910)
32. The 5-HT7 receptor is involved in allocentric spatial memory information processing. Sarkisyan G, Hedlund PB, Behav Brain Res 2009 202 26 31 10.1016/j.bbr.2009.03.011 19447277
33. Effects of the potential 5-HT7 receptor agonist AS 19 in an autoshaping learning task. Perez-Garcia GS, Meneses A, Behav Brain Res 2005 163 136 140 10.1016/j.bbr.2005.04.014 15936093 (Pubitemid 40991730)
34. NR2B tyrosine phosphorylation modulates fear learning as well as amygdaloid synaptic plasticity. Nakazawa T, Komai S, Watabe AM, Kiyama Y, Fukaya M, Arima-Yoshida F, Horai R, Sudo K, Ebine K, Delawary M, EMBO J 2006 25 2867 2877 10.1038/sj.emboj.7601156 16710293 (Pubitemid 43980393)
35. Involvement of spinal phosphorylation cascade of Tyr1472-NR2B, Thr286-CaMKII, and Ser831-GluR1 in neuropathic pain. Katano T, Nakazawa T, Nakatsuka T, Watanabe M, Yamamoto T, Ito S, Neuropharmacology 2011 60 609 616 10.1016/j.neuropharm.2010.12.005 21167847
36. Pronociceptive role of peripheral and spinal 5-HT7 receptors in the formalin test. Rocha-Gonzalez HI, Meneses A, Carlton SM, Granados-Soto V, Pain 2005 117 182 192 10.1016/j.pain.2005.06.011 16098671 (Pubitemid 41764786)
37. Systemic morphine produce antinociception mediated by spinal 5-HT7, but not 5-HT1A and 5-HT2 receptors in the spinal cord. Dogrul A, Seyrek M, Br J Pharmacol 2006 149 498 505 10.1038/sj.bjp.0706854 16921395 (Pubitemid 44658510)
38. 5-HT7 receptor activation inhibits mechanical hypersensitivity secondary to capsaicin sensitization in mice. Brenchat A, Romero L, Garcia M, Pujol M, Burgueno J, Torrens A, Hamon M, Baeyens JM, Buschmann H, Zamanillo D, Vela JM, Pain 2009 141 239 247 10.1016/j.pain.2008.11.009 19118950
39. Modulation by magnesium of the affinity of NMDA receptors for glycine in murine hippocampal neurones. Wang LY, MacDonald JF, J Physiol 1995 486 Pt 1 83 95 7562646